Skip to main content
Top
Published in: Breast Cancer 1/2017

01-01-2017 | Special Feature

The need for supplemental breast cancer screening modalities: a perspective of population-based breast cancer screening programs in Japan

Author: Takayoshi Uematsu

Published in: Breast Cancer | Issue 1/2017

Login to get access

Abstract

Purpose

This article discusses possible supplemental breast cancer screening modalities for younger women with dense breasts from a perspective of population-based breast cancer screening program in Japan.

Conclusion

Supplemental breast cancer screening modalities have been proposed to increase the sensitivity and detection rates of early stage breast cancer in women with dense breasts; however, there are no global guidelines that recommend the use of supplemental breast cancer screening modalities in such women. Also, no criterion standard exists for breast density assessment. Based on the current situation of breast imaging in Japan, the possible supplemental breast cancer screening modalities are ultrasonography, digital breast tomosynthesis, and breast magnetic resonance imaging. An appropriate population-based breast cancer screening program based on the balance between cost and benefit should be a high priority. Further research based on evidence-based medicine is encouraged. It is very important that the ethnicity, workforce, workflow, and resources for breast cancer screening in each country should be considered when considering supplemental breast cancer screening modalities for women with dense breasts.
Literature
1.
2.
go back to reference Suzuki A, Kuriyama S, Kawai M, Amari M, Takeda M, Ishida T, et al. Age-specific interval breast cancers in Japan: estimation of the proper sensitivity of screening using a population-based cancer registry. Cancer Sci. 2008;99:2264–7.CrossRefPubMed Suzuki A, Kuriyama S, Kawai M, Amari M, Takeda M, Ishida T, et al. Age-specific interval breast cancers in Japan: estimation of the proper sensitivity of screening using a population-based cancer registry. Cancer Sci. 2008;99:2264–7.CrossRefPubMed
3.
go back to reference Nagata C, Matsubara T, Fujita H, Nagao Y, Shibuya C, Kashiki Y, et al. Mammographic density and the risk of breast cancer in Japanese women. Br J Cancer. 2005;92:2102–6.CrossRefPubMedPubMedCentral Nagata C, Matsubara T, Fujita H, Nagao Y, Shibuya C, Kashiki Y, et al. Mammographic density and the risk of breast cancer in Japanese women. Br J Cancer. 2005;92:2102–6.CrossRefPubMedPubMedCentral
4.
go back to reference Matsuda T, Marugame T, Kamo K, Katanoda K, Ajiki W, Sobue T, Japan Cancer Surveillance Research Group. Cancer incidence and incidence rates in Japan in based on data from 15 population-based cancer registries in the monitoring of cancer incidence in Japan (MCIJ) project. Jpn J Clin Oncol. 2006;42:139–47.CrossRef Matsuda T, Marugame T, Kamo K, Katanoda K, Ajiki W, Sobue T, Japan Cancer Surveillance Research Group. Cancer incidence and incidence rates in Japan in based on data from 15 population-based cancer registries in the monitoring of cancer incidence in Japan (MCIJ) project. Jpn J Clin Oncol. 2006;42:139–47.CrossRef
6.
go back to reference Maskarinec G, Nagata C, Shimizu H, Kashiki Y. Comparison of mammographic densities and their determinants in women from Japan and Hawaii. Int J Cancer. 2002;102:29–33.CrossRefPubMed Maskarinec G, Nagata C, Shimizu H, Kashiki Y. Comparison of mammographic densities and their determinants in women from Japan and Hawaii. Int J Cancer. 2002;102:29–33.CrossRefPubMed
7.
go back to reference Tan SM, Evans AJ, Lam TP, Cheung KL. How relevant is breast cancer screening in the Asia/Pacific region? Breast. 2007;16:113–9.CrossRefPubMed Tan SM, Evans AJ, Lam TP, Cheung KL. How relevant is breast cancer screening in the Asia/Pacific region? Breast. 2007;16:113–9.CrossRefPubMed
8.
go back to reference Kasahara Y, Kawai M, Tsuji I, Tohno E, Yokoe T, Irahara M, et al. Harms of screening mammography for breast cancer in Japanese women. Breast Cancer. 2013;20:310–5.CrossRefPubMed Kasahara Y, Kawai M, Tsuji I, Tohno E, Yokoe T, Irahara M, et al. Harms of screening mammography for breast cancer in Japanese women. Breast Cancer. 2013;20:310–5.CrossRefPubMed
9.
go back to reference Tsuchida J, Nagahashi M, Rashid OM, Takabe K, Wakai T. At what age should screening mammography be recommended for Asian women? Cancer Med. 2015;4:1136–44.CrossRefPubMedPubMedCentral Tsuchida J, Nagahashi M, Rashid OM, Takabe K, Wakai T. At what age should screening mammography be recommended for Asian women? Cancer Med. 2015;4:1136–44.CrossRefPubMedPubMedCentral
12.
go back to reference Leong SP, Shen ZZ, Liu TJ, Agarwal G, Tajima T, Paik NS, et al. Is breast cancer the same disease in Asian and Western countries? World J Surg. 2010;34:2308–24.CrossRefPubMedPubMedCentral Leong SP, Shen ZZ, Liu TJ, Agarwal G, Tajima T, Paik NS, et al. Is breast cancer the same disease in Asian and Western countries? World J Surg. 2010;34:2308–24.CrossRefPubMedPubMedCentral
13.
go back to reference Sickles EA, D’Orsi CJ, Bassett LW, Appleton CM, Berg WA, Burnside ES. ACR BI-RADS–mammography 2013. In: Reston VA, editor. ACR BI-RADS atlas breast imaging reporting and data system. 5th ed. Reston: American College of Radiology; 2014. Sickles EA, D’Orsi CJ, Bassett LW, Appleton CM, Berg WA, Burnside ES. ACR BI-RADS–mammography 2013. In: Reston VA, editor. ACR BI-RADS atlas breast imaging reporting and data system. 5th ed. Reston: American College of Radiology; 2014.
14.
go back to reference Freer PE. Mammographic breast density: impact on breast cancer risk and implications for screening. Radiographics. 2015;35:302–15.CrossRefPubMed Freer PE. Mammographic breast density: impact on breast cancer risk and implications for screening. Radiographics. 2015;35:302–15.CrossRefPubMed
15.
go back to reference Melnikow J, Fenton JJ, Whitlock EP, Miglioretti DL, Weyrich MS, Thompson JH, et al. Supplemental screening for breast cancer in women with dense breasts: a systematic review for the U.S. preventive services task force. Ann Intern Med. 2016;164:268–78.CrossRefPubMed Melnikow J, Fenton JJ, Whitlock EP, Miglioretti DL, Weyrich MS, Thompson JH, et al. Supplemental screening for breast cancer in women with dense breasts: a systematic review for the U.S. preventive services task force. Ann Intern Med. 2016;164:268–78.CrossRefPubMed
16.
go back to reference Brandt KR, Scott CG, Ma L, Mahmoudzadeh AP, Jensen MR, Whaley DH, et al. Comparison of clinical and automated breast density measurements: implications for risk prediction and supplemental screening. Radiology. 2016;279:710–9.CrossRefPubMed Brandt KR, Scott CG, Ma L, Mahmoudzadeh AP, Jensen MR, Whaley DH, et al. Comparison of clinical and automated breast density measurements: implications for risk prediction and supplemental screening. Radiology. 2016;279:710–9.CrossRefPubMed
17.
go back to reference Pisano ED, Gatsonis C, Hendrick E, Yaffe M, Baum JK, Acharyya S, Conant EF, Digital Mammographic Imaging Screening Trial (DMIST) Investigators Group, et al. Diagnostic performance of digital versus film mammography for breast-cancer screening. N Engl J Med. 2005;353:1773–83.CrossRefPubMed Pisano ED, Gatsonis C, Hendrick E, Yaffe M, Baum JK, Acharyya S, Conant EF, Digital Mammographic Imaging Screening Trial (DMIST) Investigators Group, et al. Diagnostic performance of digital versus film mammography for breast-cancer screening. N Engl J Med. 2005;353:1773–83.CrossRefPubMed
18.
go back to reference Kerlikowske K, Hubbard RA, Miglioretti DL, Geller BM, Yankaskas BC, Lehman CD, Breast Cancer Surveillance Consortium, et al. Comparative effectiveness of digital versus film-screen mammography in community practice in the United States: a cohort study. Ann Intern Med. 2011;155:493–502.CrossRefPubMedPubMedCentral Kerlikowske K, Hubbard RA, Miglioretti DL, Geller BM, Yankaskas BC, Lehman CD, Breast Cancer Surveillance Consortium, et al. Comparative effectiveness of digital versus film-screen mammography in community practice in the United States: a cohort study. Ann Intern Med. 2011;155:493–502.CrossRefPubMedPubMedCentral
19.
go back to reference Berg WA, Blume JD, Cormack JB, Mendelson EB, Lehrer D, Böhm-Vélez M, ACRIN 6666 Investigators, et al. Combined screening with ultrasound and mammography vs mammography alone in women at elevated risk of breast cancer. JAMA. 2008;299:2151–63.CrossRefPubMedPubMedCentral Berg WA, Blume JD, Cormack JB, Mendelson EB, Lehrer D, Böhm-Vélez M, ACRIN 6666 Investigators, et al. Combined screening with ultrasound and mammography vs mammography alone in women at elevated risk of breast cancer. JAMA. 2008;299:2151–63.CrossRefPubMedPubMedCentral
20.
go back to reference Crystal P, Strano SD, Shcharynski S, Koretz MJ. Using sonography to screen women with mammographically dense breasts. Am J Roentgenol. 2003;181:177–82.CrossRef Crystal P, Strano SD, Shcharynski S, Koretz MJ. Using sonography to screen women with mammographically dense breasts. Am J Roentgenol. 2003;181:177–82.CrossRef
21.
go back to reference Ohuchi N, Suzuki A, Sobue T, Kawai M, Yamamoto S, Zheng YF, J-START investigator groups, et al. Sensitivity and specificity of mammography and adjunctive ultrasonography to screen for breast cancer in the Japan Strategic Anti-cancer Randomized Trial (J-START): a randomised controlled trial. Lancet. 2016;387:341–8.CrossRefPubMed Ohuchi N, Suzuki A, Sobue T, Kawai M, Yamamoto S, Zheng YF, J-START investigator groups, et al. Sensitivity and specificity of mammography and adjunctive ultrasonography to screen for breast cancer in the Japan Strategic Anti-cancer Randomized Trial (J-START): a randomised controlled trial. Lancet. 2016;387:341–8.CrossRefPubMed
22.
go back to reference Tohno E, Umemoto T, Sasaki K, Morishima I, Ueno E. Effect of adding screening ultrasonography to screening mammography on patient recall and cancer detection rates: a retrospective study in Japan. Eur J Radiol. 2013;82:1227–30.CrossRefPubMed Tohno E, Umemoto T, Sasaki K, Morishima I, Ueno E. Effect of adding screening ultrasonography to screening mammography on patient recall and cancer detection rates: a retrospective study in Japan. Eur J Radiol. 2013;82:1227–30.CrossRefPubMed
24.
go back to reference Skaane P, Bandos AI, Gullien R, Eben EB, Ekseth U, Haakenaasen U, et al. Comparison of digital mammography alone and digital mammography plus tomosynthesis in a population-based screening program. Radiology. 2013;267:47–56.CrossRefPubMed Skaane P, Bandos AI, Gullien R, Eben EB, Ekseth U, Haakenaasen U, et al. Comparison of digital mammography alone and digital mammography plus tomosynthesis in a population-based screening program. Radiology. 2013;267:47–56.CrossRefPubMed
25.
go back to reference Skaane P, Bandos AI, Gullien R, Eben EB, Ekseth U, Haakenaasen U, et al. Prospective trial comparing full-field digital mammography (FFDM) versus combined FFDM and tomosynthesis in a population-based screening programme using independent double reading with arbitration. Eur Radiol. 2013;23:2061–71.CrossRefPubMedPubMedCentral Skaane P, Bandos AI, Gullien R, Eben EB, Ekseth U, Haakenaasen U, et al. Prospective trial comparing full-field digital mammography (FFDM) versus combined FFDM and tomosynthesis in a population-based screening programme using independent double reading with arbitration. Eur Radiol. 2013;23:2061–71.CrossRefPubMedPubMedCentral
26.
go back to reference Friedewald SM, Rafferty EA, Rose SL, Durand MA, Plecha DM, Greenberg JS, et al. Breast cancer screening using tomosynthesis in combination with digital mammography. JAMA. 2014;311:2499–507.CrossRefPubMed Friedewald SM, Rafferty EA, Rose SL, Durand MA, Plecha DM, Greenberg JS, et al. Breast cancer screening using tomosynthesis in combination with digital mammography. JAMA. 2014;311:2499–507.CrossRefPubMed
27.
28.
go back to reference Svahn TM, Houssami N, Sechopoulos I, Mattsson S. Review of radiation dose estimates in digital breast tomosynthesis relative to those in two-view full-field digital mammography. Breast. 2015;24:93–9.CrossRefPubMed Svahn TM, Houssami N, Sechopoulos I, Mattsson S. Review of radiation dose estimates in digital breast tomosynthesis relative to those in two-view full-field digital mammography. Breast. 2015;24:93–9.CrossRefPubMed
29.
go back to reference Skaane P, Bandos AI, Eben EB, Jebsen IN, Krager M, Haakenaasen U, et al. Two-view digital breast tomosynthesis screening with synthetically reconstructed projection images: comparison with digital breast tomosynthesis with full-field digital mammographic images. Radiology. 2014;271:655–63.CrossRefPubMed Skaane P, Bandos AI, Eben EB, Jebsen IN, Krager M, Haakenaasen U, et al. Two-view digital breast tomosynthesis screening with synthetically reconstructed projection images: comparison with digital breast tomosynthesis with full-field digital mammographic images. Radiology. 2014;271:655–63.CrossRefPubMed
30.
go back to reference Houssami N, Lång K, Bernardi D, Tagliafico A, Zackrisson S, Skaane P. Digital breast tomosynthesis (3D-mammography) screening: a pictorial review of screen-detected cancers and false recalls attributed to tomosynthesis in prospective screening trials. Breast. 2016;26:119–34.CrossRefPubMed Houssami N, Lång K, Bernardi D, Tagliafico A, Zackrisson S, Skaane P. Digital breast tomosynthesis (3D-mammography) screening: a pictorial review of screen-detected cancers and false recalls attributed to tomosynthesis in prospective screening trials. Breast. 2016;26:119–34.CrossRefPubMed
31.
go back to reference Uematsu T, Yuen S, Kasami M, Uchida Y. Comparison of magnetic resonance imaging, multidetector row computed tomography, ultrasonography, and mammography for tumor extension of breast cancer. Breast Cancer Res Treat. 2008;112:461–74.CrossRefPubMed Uematsu T, Yuen S, Kasami M, Uchida Y. Comparison of magnetic resonance imaging, multidetector row computed tomography, ultrasonography, and mammography for tumor extension of breast cancer. Breast Cancer Res Treat. 2008;112:461–74.CrossRefPubMed
32.
go back to reference Berg WA, Blume JD, Adams AM, Jong RA, Barr RG, Lehrer DE, et al. Reasons women at elevated risk of breast cancer refuse breast MR imaging screening: ACRIN 6666. Radiology. 2010;254:79–87.CrossRefPubMed Berg WA, Blume JD, Adams AM, Jong RA, Barr RG, Lehrer DE, et al. Reasons women at elevated risk of breast cancer refuse breast MR imaging screening: ACRIN 6666. Radiology. 2010;254:79–87.CrossRefPubMed
33.
go back to reference Kuhl CK, Schrading S, Strobel K, Schild HH, Hilgers RD, Bieling HB. Abbreviated breast magnetic resonance imaging (MRI): first postcontrast subtracted images and maximum-intensity projection—a novel approach to breast cancer screening with MRI. J Clin Oncol. 2014;32:2304–10.CrossRefPubMed Kuhl CK, Schrading S, Strobel K, Schild HH, Hilgers RD, Bieling HB. Abbreviated breast magnetic resonance imaging (MRI): first postcontrast subtracted images and maximum-intensity projection—a novel approach to breast cancer screening with MRI. J Clin Oncol. 2014;32:2304–10.CrossRefPubMed
34.
go back to reference Rhodes DJ, Hruska CB, Conners AL, Tortorelli CL, Maxwell RW, Jones KN, et al. Molecular breast imaging at reduced radiation dose for supplemental screening in mammographically dense breasts. Am J Roentgenol. 2015;204:241–51.CrossRef Rhodes DJ, Hruska CB, Conners AL, Tortorelli CL, Maxwell RW, Jones KN, et al. Molecular breast imaging at reduced radiation dose for supplemental screening in mammographically dense breasts. Am J Roentgenol. 2015;204:241–51.CrossRef
35.
go back to reference Yamamoto Y, Tasaki Y, Kuwada Y, Ozawa Y, Inoue T. A preliminary report of breast cancer screening by positron emission mammography. Ann Nucl Med. 2016;30:130–7.CrossRefPubMed Yamamoto Y, Tasaki Y, Kuwada Y, Ozawa Y, Inoue T. A preliminary report of breast cancer screening by positron emission mammography. Ann Nucl Med. 2016;30:130–7.CrossRefPubMed
36.
go back to reference Berg WA. Nuclear breast imaging: clinical results and future directions. J Nucl Med. 2016;57:46S–52S.CrossRefPubMed Berg WA. Nuclear breast imaging: clinical results and future directions. J Nucl Med. 2016;57:46S–52S.CrossRefPubMed
Metadata
Title
The need for supplemental breast cancer screening modalities: a perspective of population-based breast cancer screening programs in Japan
Author
Takayoshi Uematsu
Publication date
01-01-2017
Publisher
Springer Japan
Published in
Breast Cancer / Issue 1/2017
Print ISSN: 1340-6868
Electronic ISSN: 1880-4233
DOI
https://doi.org/10.1007/s12282-016-0707-2

Other articles of this Issue 1/2017

Breast Cancer 1/2017 Go to the issue
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine